<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Katsuyama T</submitter><funding>NIAID NIH HHS</funding><funding>NIAMS NIH HHS</funding><funding>NIH</funding><funding>SICPA</funding><pagination>5411-5423</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6877308</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>129(12)</volume><pubmed_abstract>Systemic lupus erythematosus (SLE) is a devastating autoimmune disease in which hyperactive T cells play a critical role. Understanding molecular mechanisms underlying the T cell hyperactivity will lead to identification of specific therapeutic targets. Serine/arginine-rich splicing factor 1 (SRSF1) is an essential RNA-binding protein that controls posttranscriptional gene expression. We have demonstrated that SRSF1 levels are aberrantly decreased in T cells from patients with SLE and that they correlate with severe disease, yet the role of SRSF1 in T cell physiology and autoimmune disease is largely unknown. Here we show that T cell-restricted Srsf1-deficient mice develop systemic autoimmunity and lupus-nephritis. Mice exhibit increased frequencies of activated/effector T cells producing </pubmed_abstract><journal>The Journal of clinical investigation</journal><pubmed_title>Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity.</pubmed_title><pmcid>PMC6877308</pmcid><funding_grant_id>R01AI42269</funding_grant_id><funding_grant_id>K01 AR060781</funding_grant_id><funding_grant_id>xxxx</funding_grant_id><funding_grant_id>R01 AI042269</funding_grant_id><funding_grant_id>R01 AR068974</funding_grant_id><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Comte D</pubmed_authors><pubmed_authors>Katsuyama T</pubmed_authors><pubmed_authors>Tsokos GC</pubmed_authors><pubmed_authors>Moulton VR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity.</name><description>Systemic lupus erythematosus (SLE) is a devastating autoimmune disease in which hyperactive T cells play a critical role. Understanding molecular mechanisms underlying the T cell hyperactivity will lead to identification of specific therapeutic targets. Serine/arginine-rich splicing factor 1 (SRSF1) is an essential RNA-binding protein that controls posttranscriptional gene expression. We have demonstrated that SRSF1 levels are aberrantly decreased in T cells from patients with SLE and that they correlate with severe disease, yet the role of SRSF1 in T cell physiology and autoimmune disease is largely unknown. Here we show that T cell-restricted Srsf1-deficient mice develop systemic autoimmunity and lupus-nephritis. Mice exhibit increased frequencies of activated/effector T cells producing </description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2025-04-26T01:28:29.461Z</modification><creation>2025-04-06T10:02:59.494Z</creation></dates><accession>S-EPMC6877308</accession><cross_references><pubmed>31487268</pubmed><doi>10.1172/jci127949</doi><doi>10.1172/JCI127949</doi></cross_references></HashMap>